title: An appendix to the 2012 IOF-ECTS guidelines for the management of glucocorticoid-induced osteoporosis.
abstract: The use of glucocorticoids in the treatment of medical disorders can lead to rapid bone loss and increased risk of fragility fracture. Updated clinical guidelines are needed that accommodate recent advances in fracture risk assessment and new pharmacological interventions to reduce fracture risk. This document serves as an appendix to the 2012 IOF-ECTS guidelines for the management of glucocorticoid-induced osteoporosis.
authors.affiliation: Centre for Metabolic Bone Diseases, Department of Medicine, Faculty of Medicine, Galle, Sri Lanka.
authors.forename: S
authors.initials: S
authors.lastname: Lekamwasam
authors.forename: J D
authors.initials: JD
authors.lastname: Adachi
authors.forename: D
authors.initials: D
authors.lastname: Agnusdei
authors.forename: J
authors.initials: J
authors.lastname: Bilezikian
authors.forename: S
authors.initials: S
authors.lastname: Boonen
authors.forename: F
authors.initials: F
authors.lastname: Borgström
authors.forename: C
authors.initials: C
authors.lastname: Cooper
authors.forename: A Diez
authors.initials: AD
authors.lastname: Perez
authors.forename: R
authors.initials: R
authors.lastname: Eastell
authors.forename: L C
authors.initials: LC
authors.lastname: Hofbauer
authors.forename: J A
authors.initials: JA
authors.lastname: Kanis
authors.forename: B L
authors.initials: BL
authors.lastname: Langdahl
authors.forename: O
authors.initials: O
authors.lastname: Lesnyak
authors.forename: R
authors.initials: R
authors.lastname: Lorenc
authors.forename: E
authors.initials: E
authors.lastname: McCloskey
authors.forename: O D
authors.initials: OD
authors.lastname: Messina
authors.forename: N
authors.initials: N
authors.lastname: Napoli
authors.forename: B
authors.initials: B
authors.lastname: Obermayer-Pietsch
authors.forename: S H
authors.initials: SH
authors.lastname: Ralston
authors.forename: P N
authors.initials: PN
authors.lastname: Sambrook
authors.forename: S
authors.initials: S
authors.lastname: Silverman
authors.forename: M
authors.initials: M
authors.lastname: Sosa
authors.forename: J
authors.initials: J
authors.lastname: Stepan
authors.forename: G
authors.initials: G
authors.lastname: Suppan
authors.forename: D A
authors.initials: DA
authors.lastname: Wahl
authors.forename: J E
authors.initials: JE
authors.lastname: Compston
mesh_terms: D018501:Antirheumatic Agents / Q000627:therapeutic use*; D005938:Glucocorticoids / Q000009:adverse effects*; D006801:Humans; D010024:Osteoporosis / Q000139:chemically induced* / Q000188:drug therapy* / Q000517:prevention & control; D012216:Rheumatic Diseases / Q000188:drug therapy*
chemical_list: D018501:Antirheumatic Agents; D005938:Glucocorticoids